Weiqi Zeng

Weiqi Zeng

Auto-generated profile, based on publicly available information

Weiqi Zeng

Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
THTieying Hou
Tieying Hou
WZWeiqi Zeng
Weiqi Zeng
MYMinling Yang
Minling Yang
WCWenjing Chen
Wenjing Chen
LRLili Ren
Lili Ren
TXTeng Xu
Teng Xu
The recent outbreak of human infections caused by SARS-CoV-2, the third zoonotic coronavirus has raised great public health concern globally. Rapid and accurate diagnosis of this novel pathogen posts great challenges not only clinically but also technologically. Metagenomic next-generation sequencing (mNGS) and reverse-transcription PCR (RT-PCR) have been the most commonly used molecular methodologies. However, each has their own limitations. In this study, we developed an isothermal, CRISPR-based diagnostic for COVID-19 with near single-copy sensitivity. The diagnostic performances of all three technology platforms were also compared. Our study aimed to provide more insights into the molecular detection of SARS-CoV-2, and also to present a novel diagnostic option for this new emerging virus. The recently discovered betacoronavirus severe acute respiratory syndrome (SARS)-CoV-2 has caused an outbreak of Coronavirus Disease 2019 (COVID-19) that rapidly developed into a global pandemic. The surging demand for rapid screening and identification of COVID-19 posts great diagnostic challenges. A lack of rapid and accurate molecular tools has hampered efficient public health responses to the viral threat. Here, we harnessed the unique collateral activity of programmable CRISPR/Cas13a to develop CRISPR-COVID, a rapid and sensitive diagnostic for SARS-CoV-2 infection, and compared it to sequencing-based metagenomic and RT-PCR-based assays in a clinical cohort. CRISPR-COVID demonstrated a sensitivity level of near single copy and was highly specific without cross reacting to related pathogens. CRISPR-COVID takes only 40 mins and requires no sophiscated thermo-cyclers, providing a valuable alternative to the conventional RT–PCR assay to circumvent the bottlenecks in assay turnaround time, equipment and reagent supplies for COVID-19 testing.

11 August 2004 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
YZYing Zhu
Ying Zhu
YWYuequn Wang
Yuequn Wang
CXChunzhi Xia
Chunzhi Xia
DLDali Li
Dali Li
YLYongqing Li
Yongqing Li
MLMingyao Liu
Mingyao Liu

14 November 2008 in Cancer Research
Verified
Journal Article
Closed access
PDF file
YHYelin Huang
Yelin Huang
JZJianglin Zhang
Jianglin Zhang
KMKevin T. McHenry
Kevin T. McHenry
MKMihee M. Kim
Mihee M. Kim
WZWeiqi Zeng
Weiqi Zeng
ZYZhi-Min Yuan
Zhi-Min Yuan
Although epidemiologic studies have linked arsenic exposure to the development of human cancer, the mechanisms underlying the tumorigenic role of arsenic remain largely undefined. We report here that treatment of cells with sodium arsenite at the concentrations close to environmental exposure is associated with the up-regulation of Hdm2 and the accumulation of p53 in the cytoplasm. Through the mitogen-activated protein kinase pathway, arsenite stimulates the P2 promoter–mediated expression of Hdm2, which then promotes p53 nuclear export. As a consequence, the p53 response to genotoxic stress is compromised, as evidenced by the impaired p53 activation and apoptosis in response to UV irradiation or 5FU treatment. The ability of arsenite to impede p53 activation is further demonstrated by a significantly blunted p53-dependent tissue response to 5FU treatment when mice were fed with arsenite-containing water. Together, our data suggests that arsenic compounds predispose cells to malignant transformation by up-regulation of Hdm2 and subsequent p53 inactivation. [Cancer Res 2008;68(22):9131–6]

12 January 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
ZLZhongling Luo
Zhongling Luo
XZXu Zhang
Xu Zhang
WZWeiqi Zeng
Weiqi Zeng
JSJuan Su
Juan Su
KYKeda Yang
Keda Yang
XCXiang Chen
Xiang Chen
TRAF6 regulates melanoma invasion and metastasis through ubiquitination of Basigin

1 September 2013 in Cancer Letters
Verified
Journal Article
Closed access
SZShuangyuan Zhou
Shuangyuan Zhou
LLLiqiu Liao
Liqiu Liao
CCChen Chen
Chen Chen
WZWeiqi Zeng
Weiqi Zeng
SLShuang Liu
Shuang Liu
JLJie Li
Jie Li

1 December 2004 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YLYongqing Li
Yongqing Li
YWYuequn Wang
Yuequn Wang
CZCaibo Zhang
Caibo Zhang
WYWuzhou Yuan
Wuzhou Yuan
JWJun Wang
Jun Wang
MLMingyao Liu
Mingyao Liu